Cambize Shahrdar, MD
Orthopaedic Surgery · Shreveport, LANPI 1841229978
Payments from drug & device makers
Across 34 payments — averaging $95.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Zimmer Biomet$877
- Sanara Medtech Inc.$399
- Davol Inc.$203
- Heron Therapeutics, Inc.$152
- Orthalign Inc$150
- plus $332 from 10 others
What the payments were for
- Travel & lodging$95929%
- Food & beverage$2,30171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 9 | $1,148 |
| Zimmer Biomet | 9 | $877 |
| Sanara Medtech Inc. | 2 | $399 |
| Davol Inc. | 1 | $203 |
| Heron Therapeutics, Inc. | 1 | $152 |
| Orthalign Inc | 1 | $150 |
| Baudax Bio Inc. | 1 | $83 |
| Medtronic | 1 | $50 |
| Biocomposites Inc | 1 | $46 |
| Bioventus LLC | 2 | $46 |
| Alafair Biosciences, Inc. | 1 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Vertex | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,039
- CellerateRx$215
- ARISTA$203
- Biasurge$183
- ORTHALIGN PLUS$150
- ROSA-Knee$137
How this compares
$3,259 in reported general payments places this provider in the 45th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 60 | $4,666 |
| Linezolid | 20 | $2,183 |
| Tranexamic Acid | 136 | $1,794 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 89 | $1,058 |
| Meloxicam | 178 | $748 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 124 | $741 |
| Cephalexin | 160 | $565 |
| Doxycycline Hyclate | 147 | $344 |
| Doxycycline Monohydrate | 42 | $307 |
| Celecoxib | 13 | $303 |
| Gabapentin | 54 | $282 |
| Ondansetron OdtOndansetron | 58 | $236 |
| Ketorolac Tromethamine | 17 | $195 |
| Duloxetine Hcl | 19 | $121 |
| Amoxicillin | 99 | $94 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Shreveport
- Pierce NunleyShreveport$3.8M
- Steven AtchisonShreveport$170K
- Mark CallananShreveport$102K
- Timothy TalbertShreveport$68K
- Stephen CoxShreveport$61K
- John GoogeShreveport$57K
- Michael NammourShreveport$38K
- Eubulus KerrShreveport$37K
- Massimo MorandiShreveport$28K
- Christopher CaldwellShreveport$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.